« Back
Significant Increase in Utilization of Multiparametric Prostate MRI in Patients Prior to Prostatectomy from 2012-2017
Significant Increase in Utilization of Multiparametric Prostate MRI in Patients Prior to Prostatectomy from 2012-2017
Submitted on 14 Sep 2018

Candice Kim, Jinxing Yu, Sarah Winks
Virginia Commonwealth University
Poster Views: 160
View poster »
Poster Abstract
To evaluate trends in frequency and indications for obtainment of prostate multiparametric MRI over the past six years (2012-2017).

Materials and Methods
Through a database search spanning January 1, 2012 to December 31, 2017, 277 patients with prostatectomies performed at a single institution were identified. Of these, 39 had a prostate MRI prior to the procedure. Indications for prostate MRI were categorized into 3 groups: detection (no prior established diagnosis of prostate cancer), staging (exclusion of extracapsular or seminal vesicle invasion) and active surveillance.

An upward trend in prostate MRI use prior to prostatectomy was noted over the last 6 years. The increase in use of prostate MRI in 2017 compared to 2012 was 433%. Prostate MRI obtained prior to prostatectomy was 2 of 37 prostatectomies in 2012 (5%), 6 of 66 in 2013 (9%), 5 out of 56 in 2014 (9%), 7 of 43 in 2015 (16%), 5 of 34 in 2016 (15%), and 14 of 41 in 2017 (34%). Indications from most to least common were detection, staging, and active surveillance. Detection has remained the most common indication, while active surveillance has gradually become more common over time. Additionally, the percentage of patients undergoing prostate MRI for tumor detection without prior TRUS biopsy has increased over time: 0% in 2013 and 2014, 66% in 2015, 75% in 2016, and 90% in 2017.

Prostate MRI prior to prostatectomy is performed increasingly year over year at our institution. Detection has remained the most common indication followed by staging and active surveillance. More and more patients had prostate MRI for detection without prior TRUS biopsy.Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

A Novel Enzymatic Assay for Determination of Phosphatidylinositol in Biological Samples
Paul Templeton, Kyle C. Schmitt, Grigoriy Tchaga,and Gordon Yan

A Novel Method For Discovery of Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis Using Extensive Depletion and TMTcalibratorTM Tissue-Enhanced Plasma Proteomics
I. Pike1, M. Bremang1, P.J. Wolters 2, R. Gaster3, S. Turner3, M. Decaris3

Nikita Gandotra

Things just keep changing: Family caregivers' perceptions of the impact of Huntington's disease on caregiver burden
Jess Kaplonyi, Dr Christopher Lind, Catherine Christian, Irene Scott

The EurOPDX EDIReX project: towards a European Research Infrastructure on patient-derived cancer models
E. Vinolo 1, J.P. Morris 1, D.G. Alférez 2, J. Arribas 3,4,5, C. Bernadó 3,4,5, A. Bertotti 6, A. Bruna 7, A.T. Byrne 8, C. Caldas 7, R.B. Clarke 2, N. Conte 9, R. Corsi 10, S. Corso 6, M. Crespo 3, A. Dahmani 11, V. Dangles-Marie 11, D. Decaudin 11, Z. Dudová 12, A. Fiori 6, S. Giordano 6, M. Hauptsmann 13, M. Hidalgo 14, C. Isella 6, S. de Jong 15, J. Jonkers 13, A. Křenek 12, O. Krijgsman 13, D. Kouřil 12, J.C. Lacal 14, L. Lanfrancone 16, E. Leucci 17, G.M. Mælandsmo 18, E. Marangoni 11, J. Mason 9, M.Th. Mayrhofer 19, A. Mazzocca 6, T.S. Meehan 9, E. Montaudon 11, F. Nem